Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Simple item page
dc.contributor.authorFeagan, Brian G.
dc.contributor.authorRutgeerts, Paul
dc.contributor.authorSands, Bruce E.
dc.contributor.authorHanauer, Stephen
dc.contributor.authorColombel, Jean-Frédéric
dc.contributor.authorSandborn, William J.
dc.contributor.authorVan Assche, Gert
dc.contributor.authorAxler, Jeffrey
dc.contributor.authorKim, Hyo-Jong
dc.contributor.authorDanese, Silvio
dc.contributor.authorPavli, Paul
dc.date.accessioned2015-12-10T22:35:12Z
dc.date.issued2013
dc.date.updated2015-12-09T10:26:05Z
dc.identifier.issn0028-4793
dc.identifier.urihttp://hdl.handle.net/1885/56165
dc.publisherMassachusetts Medical Society
dc.sourceNew England Journal of Medicine
dc.titleVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
dc.typeJournal article
local.bibliographicCitation.issue8
local.bibliographicCitation.lastpage710
local.bibliographicCitation.startpage699
local.contributor.affiliationFeagan, Brian G., University of Western Ontario
local.contributor.affiliationRutgeerts, Paul, University Hospital Gasthuisberg
local.contributor.affiliationSands, Bruce E., Icahn School of Medicine at Mount Sinai
local.contributor.affiliationHanauer, Stephen, University of Chicago
local.contributor.affiliationColombel, Jean-Frédéric, Icahn School of Medicine at Mount Sinai
local.contributor.affiliationSandborn, William J., University of California
local.contributor.affiliationVan Assche, Gert, Katholieke Universiteit
local.contributor.affiliationAxler, Jeffrey, Mount Sinai Hospital
local.contributor.affiliationKim, Hyo-Jong, Kyung Hee University Hospital
local.contributor.affiliationDanese, Silvio, Istituto Clinico Humanitas
local.contributor.affiliationPavli, Paul, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidPavli, Paul, u3683784
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110307 - Gastroenterology and Hepatology
local.identifier.ariespublicationu4971216xPUB353
local.identifier.citationvolume369
local.identifier.doi10.1056/NEJMoa1215734.
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Feagan_Vedolizumab_as_Induction_and_2013.pdf
Size:
940.49 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS